Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Unknown 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Breast Neoplasms 48Neoplasms 43Depression 31Fatigue 30Prostatic Neoplasms 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Lymphoma, Follicular 18Lymphoma, Large B-Cell, Diffuse 17Multiple Myeloma 16Carcinoma, Non-Small-Cell Lung 16Lymphoma, Non-Hodgkin 15Lung Neoplasms 15Leukemia, Lymphocytic, Chronic, B-Cell 15Lymphoma, Mantle-Cell 14Leukemia, Myeloid, Acute 14Hodgkin Disease 14Colorectal Neoplasms 14Burkitt Lymphoma 14Anxiety Disorders 14Pain 13Lymphoma, B-Cell, Marginal Zone 13Lymphoma, Large-Cell, Immunoblastic 12Lymphoma 11Leukemia, Myeloid, Chronic-Phase 11Head and Neck Neoplasms 11Blast Crisis 11Lymphoma, T-Cell, Cutaneous 10Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 10Leukemia, Myeloid, Accelerated Phase 10Leukemia, Hairy Cell 10

Interventions

Injections 26toripalimab 17pembrolizumab 17tislelizumab 12Gemcitabine 8Cisplatin 7spartalizumab 6atezolizumab 6Irinotecan 6Carboplatin 6Paclitaxel 5Oxaliplatin 5Nivolumab 5Leucovorin 5Fluorouracil 5camrelizumab 4Pemetrexed 4Docetaxel 4Cetuximab 4Capecitabine 4trastuzumab deruxtecan 3sintilimab 3olaparib 3lenvatinib 3cediranib 3PM 01183 3Drug Therapy 3Cyclophosphamide 3Bevacizumab 3Albumin-Bound Paclitaxel 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Advanced Solid Tumor × Therapeutics × Clear all
NCT05673538 2023-01-10

TT-00973-MS Tablets in Patients With Advanced Solid Tumors

TransThera Sciences (Nanjing), Inc.

Phase 1 Unknown
40 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT04423380 2020-06-09

A Study to Investigate Safety and Tolerability of SH3051 Capsule in Patients With Advanced Solid Tumors

Nanjing Sanhome Pharmaceutical, Co., Ltd.

Phase 1 Unknown
45 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡